Mphasis reported a 2.1% revenue growth for Q1 FY27, supported by a strong $461 million in new contract wins. While deal momentum remains robust, the company saw a slight dip in profit margins due to expansion-related costs. Investors are tracking how management balances these initial setup expenses with their goal of long-term margin stability.
Detailed Coverage
Mphasis Ltd. reported its financial results for the first quarter of fiscal year 2027, showing a sequential revenue growth of 2.1% in constant currency terms. This growth was mainly driven by the scaling up of large contracts and the integration of its OKIN acquisition. The company noted that demand remained steady within the Banking, Financial Services, and Insurance segment, which is a major area for its business. While the Insurance vertical saw a minor slowdown during the quarter, leadership indicated they expect this area to return to growth in the coming months.
Strong Deal Wins and Future Outlook
A highlight for the quarter was the company's ability to secure new business, with the net new Total Contract Value reaching US$461 million. This marks the fifth consecutive quarter that Mphasis has recorded over US$400 million in new deal signings. A significant portion, specifically 63%, of these wins are linked to Artificial Intelligence projects. Management has expressed optimism for the second quarter of FY27, forecasting its strongest sequential growth in three years, supported by the ongoing execution of these large deals and the addition of revenue from the Red Oak contract.
Impact on Profit Margins
Despite the rise in revenue, the company’s operating profit margin, or EBIT margin, slipped by 60 basis points to 14.8%. This pressure on profitability was largely caused by costs related to setting up and scaling new, large-scale projects. Additionally, one-time expenses tied to acquisitions and a drop in how much of its capacity was being used—referred to as utilization—contributed to this dip. While the company has kept its full-year EBIT margin guidance in the range of 14.75% to 15.75%, analysts have noted that these cost pressures led to a slight downward revision in earnings estimates. The company plans to address this by focusing on better utilization of resources and the normalization of one-time costs.
Investors will likely track the company's ability to improve these profit margins in the coming quarters. The key focus area will be whether the management can successfully convert the record-high deal pipeline into revenue without further margin dilution. Future updates on the execution of the Red Oak contract and progress in the TMT and insurance segments will be important for assessing the company's ability to maintain its growth trajectory.